Measurement of the top quark mass in multijet events with the CMS experiment at LHC

La massa del quark top è qui misurata per mezzo dei dati raccolti dall’esperimento CMS in collisioni protone-protone ad LHC, con energia nel centro di massa pari ad 8 TeV. Il campione di dati raccolto corrisponde ad una luminosità integrata pari a 18.2 /fb. La misura è effettuata su eventi con un numero di jet almeno pari a 6, di cui almeno due b-taggati (ovvero identificati come prodotto dell’adronizzazione di due quark bottom). Il valore di massa trovato è di (173.95 +- 0.43 (stat)) GeV/c2, in accordo con la media mondiale. The top quark mass is here measured by using the data that have been collected with the CMS experiment in proton-proton collisions at the LHC, at a center-of-mass energy of 8 TeV. The dataset which was used, corresponds to an integrated luminosiy of 18.2 /fb. The mass measurement is carried out by using events characterized by six or more jets, two of which identified as being originated by the hadronization of bottom quarks. The result of the measurement of the top quark mass performed here is: (173.95 +- 0.43 (stat)) GeV/c2, in accordance with the recently published world average.

Search for Dark Matter in events with a highly energetic jet and missing transverse momentum in proton-proton collisions at root out s = 8 TeV with the ATLAS detector

The experiments at the Large Hadron Collider at the European Centre for Particle Physics, CERN, rely on efficient and reliable trigger systems for singling out interesting events. This thesis documents two online timing monitoring tools for the central trigger of the ATLAS experiment as well as the adaption of the central trigger simulation as part of the upgrade for the second LHC run. Moreover, a search for candidates for so-called Dark Matter, for which there is ample cosmological evidence, is presented. This search for generic weakly interacting massive particles (WIMPs) is based on the roughly 20/fb of proton-proton collisions at a centre-of-mass-energy of sqrt{s}=8 TeV recorded with the ATLAS detector in 2012. The considered signature are events with a highly energetic jet and large missing transverse energy. No significant deviation from the theory prediction is observed. Exclusion limits are derived on parameters of different signal models and compared to the results of other experiments. Finally, the results of a simulation study on the potential of the analysis at sqrt{s}=14 TeV are presented.

Characteristics of multijet t/t events reconstructed by CMS in pp collisions at 13 TeV

We present here a characterization of the Monte Carlo samples used at CMS in the current LHC run (Run 2, sqrt(s)=13 TeV) and we compare them to the ones used in the previous run (Run 1, sqrt(s)=8 TeV). We then use these samples to reconstruct the top quark mass from the all-hadronic decay products and we compare the efficiencies of the standard reconstruction method when applied to the two different samples. We finally find a way to improve the efficiency for 13 TeV samples by using jets reconstructed with a different algorithm, the Cambridge-Aachen algorithm.

Controlli non distruttivi su mega-coaster: risultati sperimentali e azioni correttive

Il lavoro di tesi è focalizzato sull'utilizzo dei controlli non distruttivi (NDT) nell'ambito della manutenzione industriale, in particolare al controllo di un mega-coaster. Dopo una breve panoramica sulle tecniche di indagine più utilizzate, si prosegue nell'ambito specifico dei controlli eseguiti all'interno del parco divertimenti di Mirabilandia, sull'attrazione di punta, ovvero l'inverted-coaster "KATUN". In particolare viene descritto il controllo del tracciato dell'attrazione, ovvero del binario, mediante tecnica ad ultrasuoni. L'elaborato si conclude con un riassunto dei risultati sperimentali ottenuti ed alcune azioni correttive intraprese per il miglioramento dell'efficacia dei controlli stessi.

Differences in Demographic Characteristics and Risk Factors in Patients With Spontaneous Vertebral Artery Dissections With and Without Ischemic Events

Spontaneous vertebral artery dissection (sVADs) mainly cause cerebral ischemia, with or without associated local symptoms and signs (headache, neck pain, or cervical radiculopathy), or with local symptoms and signs only.

Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study

PURPOSE To develop a score predicting the risk of adverse events (AEs) in pediatric patients with cancer who experience fever and neutropenia (FN) and to evaluate its performance. PATIENTS AND METHODS Pediatric patients with cancer presenting with FN induced by nonmyeloablative chemotherapy were observed in a prospective multicenter study. A score predicting the risk of future AEs (ie, serious medical complication, microbiologically defined infection, radiologically confirmed pneumonia) was developed from a multivariate mixed logistic regression model. Its cross-validated predictive performance was compared with that of published risk prediction rules. Results An AE was reported in 122 (29%) of 423 FN episodes. In 57 episodes (13%), the first AE was known only after reassessment after 8 to 24 hours of inpatient management. Predicting AE at reassessment was better than prediction at presentation with FN. A differential leukocyte count did not increase the predictive performance. The score predicting future AE in 358 episodes without known AE at reassessment used the following four variables: preceding chemotherapy more intensive than acute lymphoblastic leukemia maintenance (weight = 4), hemoglobin > or = 90 g/L (weight = 5), leukocyte count less than 0.3 G/L (weight = 3), and platelet count less than 50 G/L (weight = 3). A score (sum of weights) > or = 9 predicted future AEs. The cross-validated performance of this score exceeded the performance of published risk prediction rules. At an overall sensitivity of 92%, 35% of the episodes were classified as low risk, with a specificity of 45% and a negative predictive value of 93%. CONCLUSION This score, based on four routinely accessible characteristics, accurately identifies pediatric patients with cancer with FN at risk for AEs after reassessment.

Effect of valsartan on the incidence of diabetes and cardiovascular events

It is not known whether drugs that block the renin-angiotensin system reduce the risk of diabetes and cardiovascular events in patients with impaired glucose tolerance.

Effect of nateglinide on the incidence of diabetes and cardiovascular events

The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people with impaired glucose tolerance is unknown.

Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events

Coagulation factor XIII (FXIII) stabilizes fibrin fibers and is therefore a major player in the maintenance of hemostasis. FXIII is activated by thrombin resulting in cleavage and release of the FXIII activation peptide (AP-FXIII). The objective of this study was to characterize the released AP-FXIII and determine specific features that may be used for its specific detection. We analyzed the structure of bound AP-FXIII within the FXIII A-subunit and interactions of AP-FXIII by hydrogen bonds with both FXIII A-subunit monomers. We optimized our previously developed AP-FXIII ELISA by using 2 monoclonal antibodies. We determined high binding affinities between the antibodies and free AP-FXIII and demonstrated specific binding by epitope mapping analyses with surface plasmon resonance and enzyme-linked immunosorbent assay. Because the structure of free AP-FXIII had been characterized so far by molecular modeling only, we performed structural analysis by nuclear magnetic resonance. Recombinant AP-FXIII was largely flexible both in plasma and water, differing significantly from the rigid structure in the bound state. We suggest that the recognized epitope is either occluded in the noncleaved form or possesses a structure that does not allow binding to the antibodies. On the basis of our findings, we propose AP-FXIII as a possible new marker for acute thrombotic events.